当前位置:首页 - 行情中心 - 梅花生物(600873) - 财务分析

梅花生物

(600873)

  

流通市值:312.10亿  总市值:312.10亿
流通股本:28.53亿   总股本:28.53亿

梅花生物(600873)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润17.68亿元,每股收益0.62元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益1498013.47万元,未分配利润1093860.29万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产2400149.75万元,负债902136.28万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入12,280,450,603.536,268,563,075.4625,069,288,294.6218,680,785,476.06
营业总成本10,368,912,543.025,214,885,039.0521,862,599,657.6216,648,960,494.8
其他经营收益
营业利润2,096,399,627.921,206,030,880.483,491,284,796.472,273,666,876.02
利润总额2,089,170,850.251,202,262,709.833,349,460,691.132,341,949,383.52
净利润1,767,950,116.891,018,706,366.462,740,427,215.561,995,321,648.29
每股收益
其他综合收益-98,666,362.69-78,900,353.95-60,692,608.9639,914,573.3
综合收益总额1,669,283,754.2939,806,012.512,679,734,606.62,035,236,221.59
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计8,841,594,093.269,499,388,391.598,899,880,069.398,649,625,914.87
非流动资产:
非流动资产合计15,159,903,439.8714,797,470,081.9814,909,677,942.2714,885,244,557.54
资产总计24,001,497,533.1324,296,858,473.5723,809,558,011.6623,534,870,472.41
流动负债:
流动负债合计6,847,181,423.826,991,289,327.797,438,989,489.187,268,914,553.77
非流动负债:
非流动负债合计2,174,181,395.091,854,106,796.611,795,623,221.551,547,914,394.63
负债合计9,021,362,818.918,845,396,124.49,234,612,710.738,816,828,948.4
所有者权益(或股东权益):
归属于母公司股东权益合计14,980,134,714.2215,451,462,349.1714,574,945,300.9314,718,041,524.01
股东权益合计14,980,134,714.2215,451,462,349.1714,574,945,300.9314,718,041,524.01
负债和股东权益合计24,001,497,533.1324,296,858,473.5723,809,558,011.6623,534,870,472.41
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计13,450,929,765.846,754,619,422.6828,306,256,369.4521,107,357,469.37
经营活动现金流出小计11,138,138,545.216,301,352,351.9923,679,541,578.9817,021,645,545.62
经营活动产生的现金流量净额2,312,791,220.63453,267,070.694,626,714,790.474,085,711,923.75
投资活动产生的现金流量:
投资活动现金流入小计91,637,275.9431,726,103.26245,600,886.5938,687,126
投资活动现金流出小计3,034,934,871.822,182,847,932.672,894,559,694.33,768,697,832.58
投资活动产生的现金流量净额-2,943,297,595.88-2,151,121,829.41-2,648,958,807.71-3,730,010,706.58
筹资活动产生的现金流量:
筹资活动现金流入小计3,303,480,417.491,624,172,167.726,686,830,180.65,202,360,482.5
筹资活动现金流出小计4,113,628,860.221,447,935,110.159,424,882,464.297,044,969,625.42
筹资活动产生的现金流量净额-810,148,442.73176,237,057.57-2,738,052,283.69-1,842,609,142.92
汇率变动对现金及现金等价物的影响31,539,177.2322,189,675.61111,541,460.3471,035,361.96
现金及现金等价物净增加额-1,409,115,640.75-1,499,428,025.54-648,754,840.59-1,415,872,563.79
期末现金及现金等价物余额2,722,743,961.392,632,431,576.724,131,859,602.143,364,741,878.94
补充资料:
现金及现金等价物的净增加额-1,409,115,640.75--648,754,840.59-
最新报告期:2025-08-25
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华安证券刘天其,王强峰1.211.271.382025-08-25
申万宏源周超,宋涛1.161.221.302025-08-24
长江证券马太1.111.191.232025-08-24
中金公司侯一林,裘孝锋,贾雄伟1.111.12--2025-08-20
民生证券刘海荣,李金凤1.111.141.172025-08-20
TOP↑